3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
52
Prostatic Neoplasms
23
Lung Neoplasms
17
Breast Neoplasms
17
Squamous Cell Carcinoma of Head and Neck
14
Stomach Neoplasms
10
Neoplasms
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
8
Urinary Bladder Neoplasms
6
Neoplasm Metastasis
6
Head and Neck Neoplasms
6
Carcinoma, Transitional Cell
6
Triple Negative Breast Neoplasms
5
Non-Muscle Invasive Bladder Neoplasms
5
Carcinoma, Squamous Cell
5
Prostatic Neoplasms, Castration-Resistant
4
Ovarian Neoplasms
4
Oropharyngeal Neoplasms
4
Endometrial Neoplasms
4
Small Cell Lung Carcinoma
3
Salivary Gland Neoplasms
3
Nasopharyngeal Carcinoma
3
Laryngeal Neoplasms
3
HER2-positive Breast Cancer
3
Fallopian Tube Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Carcinoma
3
Anatomic Stage I Breast Cancer AJCC v8
3
Adenocarcinoma
3
Vaccinia
2
Interventions
Cyclophosphamide
34
Vincristine
23
Methotrexate
21
blinatumomab
20
Prednisone
20
Specimen Handling
19
Cytarabine
18
merphos
16
prednylidene
15
deltacortene
15
Mercaptopurine
15
Doxorubicin
15
Dexamethasone
15
Biopsy
15
pegaspargase
13
N,N-dicyclohexyl-isoborneol-10-sulfonamide
13
azathiopurine
12
Rituximab
12
Etoposide
12
dexamethasone acetate
11
dexamethasone 21-phosphate
11
auricularum
11
Spinal Puncture
11
Leucovorin
11
Calcium Dobesilate
11
Asparaginase
11
fludarabine
10
Thioguanine
9
Magnetic Resonance Spectroscopy
9
Inotuzumab Ozogamicin
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Burkitt Lymphoma
×
Docetaxel
×
90 days
×
Clear all
No trials found.